ALFA Filings
Every announcement, straight from the exchange
Every Bacil Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Bacil Pharma Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
Bacil Pharma Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 30, 2025.
Bacil Pharma Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with regulatory disclosure requirements.
Bacil Pharma Ltd has withdrawn its intimation for appointing two independent directors. This follows a failure to receive necessary consent documents.
Nikita Hiren Patel sold a 2.27% stake in Bacil Pharma Limited via open-market transactions. Her total holding reduced from 19.44% to 17.17% following the disposal.
Bacil Pharma Limited reported zero Related Party Transactions for the half-year ended March 31, 2026. This NIL disclosure maintains regulatory compliance and transparency.